20/20 GeneSystems is a US based private corporation located in Maryland. Investment opportunities are currently available to accredited investors, family offices, private equity and venture capital firms. 20/20 GeneSystems is strongly focused on bringing its technology to Asian markets in 2016 and 2017. We welcome inquiries from investment funds focusing on biotechnology and diagnostic products with an Asian market component.
Equity Crowdfunding Opportunity
Investors who may be looking to invest small amounts may wish to participate in investing through our MicroVentures Equity Crowdfunding offering. You can receive more information at the following website.